36. Ito T, Amakawa R, Inaba M, Ikehara S, Inaba K, et al. (2001) Differential regulation of human blood dendritic cell subsets by ifns. JImmunol 166: 2961–2969. 37. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, et al. (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100: 2610–2615. 38. Cheney IW, Lai VC, Zhong W, Brodhag T, Dempsey S, et al. (2002) Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons. J Virol 76: 11148–11154. 39. Khan NU, Gibson A, Foulis AK (1990) The distribution of immunoreactive interferon-alpha in formalin-fixed paraffin-embedded normal human foetal and infant tissues. Immunology 71: 230–235. 40. Kim T, Pazhoor S, Bao M, Zhang Z, Hanabuchi S, et al. (2010) Aspartate- glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells. Proc Natl Acad Sci U S A 107: 15181–15186. 41. Jamieson BD, Uittenbogaart CH, Schmid I, Zack JA (1997) High viral burden and rapid CD4+ cell depletion in human immunodeficiency virus type 1-infected SCID-hu mice suggests direct viral killing of thymocytes in vivo. JVirology 71: 8245–8253. 42. Meager A, Visvalingam K, Peterson P, Moll K, Murumagi A, et al. (2006) Anti- interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med 3: e289. 43. Strasser A, Puthalakath H, O’Reilly LA, Bouillet P (2008) What do we know about the mechanisms of elimination of autoreactive T and B cells and what challenges remain. Immunol Cell Biol 86: 57–66. Constitutive IFN-a Expression in the Human Thymus 44. Zheng SJ, Chen YH (2003) TRAIL, Bim, and thymic-negative selection. Immunol Res 28: 295–301. 45. Mibayashi M, Nakad K, Nagata K (2002) Promoted cell death of cells expressing human MxA by influenza virus infection. Microbiol Immunol 46: 29–36. 46. Numajiri A, Mibayashi M, Nagata K (2006) Stimulus-dependent and domain- dependent cell death acceleration by an IFN-inducible protein, human MxA. J Interferon Cytokine Res 26: 214–219. 47. Gurney KB, Uittenbogaart CH (2006) Human immunodeficiency virus persistence and production in T-cell development. Clin Vaccine Immunol 13: 1237–1245. 48. Pedroza-Martins L, Gurney KB, Torbett BE, Uittenbogaart CH (1998) Differential tropism and replication kinetics of human immunodeficiency virus type 1 isolates in thymocytes: coreceptor expression allows viral entry, but productive infection of distinct subsets is determined at the postentry level. JVirol 72: 9441–9452. 49. Uittenbogaart CH, Anisman DJ, Jamieson BD, Kitchen S, Schmid I, et al. (1996) Differential tropism of HIV-1 isolates for distinct thymocyte subsets in vitro. AIDS 10: F9–F16. 50. Berkowitz RD, Alexander S, Bare C, Linquist-Stepps V, Bogan M, et al. (1998) CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo. JVirol 72: 10108–10117. 51. Jamieson BD, Pang S, Aldrovandi GM, Zha J, Zack JA (1995) In vivo pathogenic properties of two clonal human immunodeficiency virus type 1 isolates. J Virol 69: 6259–6264. 52. Kitchen SG, Zack JA (1997) CXCR4 expression during lymphopoiesis: implications for Human Immunodeficiency virus type 1 infection of the thymus. JVirology 71: 6928–6934. PLoS ONE | www.plosone.org 11 August 2011 | Volume 6 | Issue 8 | e24252